Telelap Alf-X-Assisted Laparoscopy for Ovarian Cyst Enucleation: Report of the First 10 Cases

J Minim Invasive Gynecol. Sep-Oct 2015;22(6):1079-83. doi: 10.1016/j.jmig.2015.05.007. Epub 2015 May 16.


This prospective single-institutional clinical trial sought to assess the safety and feasibility of laparoscopic benign ovarian cyst enucleation with a novel robotic-assisted laparoscopic system. Here we report a series of 10 patients treated using the Telelap ALF-X system in the first clinical application on patients at the Division of Gynecologic Oncology, Catholic University of the Sacred Heart of Rome. The primary inclusion criterion was the presence of monolateral ovarian cyst without a preoperative assessment suspicious for malignancy. Intraoperative data, including docking time, operative time, estimated blood loss, intraoperative and perioperative complications, and conversion to either standard laparoscopy or laparotomy, were collected. The cysts were removed with an ovary-sparing technique with respect to conservative surgical principles. The median operative time was 46.3 minutes, and patients without postoperative complications were discharged at 1 or 2 days after the procedure. Telelap ALF-X laparoscopic enucleation of benign ovarian cysts with an ovary-sparing technique is feasible, safe, and effective; however, more clinical data are needed to determine whether this approach can offer any other benefits over other minimally invasive surgical techniques.

Keywords: Ovarian cyst; Robotic surgery; Telelap ALF-X.

Publication types

  • Case Reports
  • Evaluation Study

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Female
  • Gynecologic Surgical Procedures* / methods
  • Humans
  • Laparoscopy* / methods
  • Middle Aged
  • Ovarian Cysts / surgery*
  • Postoperative Complications / etiology
  • Prospective Studies
  • Robotic Surgical Procedures*
  • Treatment Outcome